OWCP (OWC Pharmaceutical Research) Total Assets: $1.77 Mil (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OWC Pharmaceutical Research Total Assets?

OWC Pharmaceutical Research OWCP Total Assets is $1.77 Mil as of Sep. 2019.

OWC Pharmaceutical Research's Total Assets for the quarter that ended in Sep. 2019 was $1.77 Mil.

Total Assets is connected with ROA %. OWC Pharmaceutical Research's annualized ROA % for the quarter that ended in Sep. 2019 was -55.89%. Total Assets is also linked to Revenue through Asset Turnover. OWC Pharmaceutical Research's Asset Turnover for the quarter that ended in Sep. 2019 was 0.00.

OWC Pharmaceutical Research  (OTCPK:OWCP) Total Assets Explanation

Total Assets is connected with ROA %.

OWC Pharmaceutical Research's annualized ROA % for the quarter that ended in Sep. 2019 is

ROA %=Net Income (Q: Sep. 2019 )/( (Total Assets (Q: Jun. 2019 )+Total Assets (Q: Sep. 2019 ))/ count )
=-1.148/( (2.335+1.773)/ 2 )
=-1.148/2.054
=-55.89 %

Note: The Net Income data used here is four times the quarterly (Sep. 2019) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

OWC Pharmaceutical Research's Asset Turnover for the quarter that ended in Sep. 2019 is

Asset Turnover
=Revenue (Q: Sep. 2019 )/( (Total Assets (Q: Jun. 2019 )+Total Assets (Q: Sep. 2019 ))/ count )
=0/( (2.335+1.773)/ 2 )
=0/2.054
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

OWC Pharmaceutical Research Total Assets Related Terms

OWC Pharmaceutical Research Total Assets Historical Data

* Premium members only.

The historical data trend for OWC Pharmaceutical Research's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research Total Assets Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Total Assets
Get a 7-Day Free Trial Premium Member Only 1.52 0.43 0.50 1.06 3.55

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.31 3.55 2.95 2.34 1.77

OWC Pharmaceutical Research Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

OWC Pharmaceutical Research's Total Assets for the fiscal year that ended in Dec. 2018 is calculated as

Total Assets=Total Equity (A: Dec. 2018 )+Total Liabilities (A: Dec. 2018 )
=-9.44+12.993
=3.55

OWC Pharmaceutical Research's Total Assets for the quarter that ended in Sep. 2019 is calculated as

Total Assets=Total Equity (Q: Sep. 2019 )+Total Liabilities (Q: Sep. 2019 )
=-4.008+5.781
=1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $1.77 Mil mean?
OWC Pharmaceutical Research (OWCP) has a Total Assets of $1.77 Mil as of Sep. 2019. The total amount of assets as recorded on a company's balance sheet. View historical data on OWC Pharmaceutical Research and its competitors.
Is OWC Pharmaceutical Research's Total Assets too high?
OWC Pharmaceutical Research's current Total Assets is $1.77 Mil.
How does OWC Pharmaceutical Research's Total Assets compare to PARNF and CANB?
OWC Pharmaceutical Research's Total Assets of $1.77 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on OWC Pharmaceutical Research and its competitors. OWC Pharmaceutical Research's current Total Assets is $1.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OWC Pharmaceutical Research stock overvalued right now?
OWC Pharmaceutical Research (OWCP) has a current Total Assets of $1.77 Mil. The current Total Assets is $1.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For OWC Pharmaceutical Research (OWCP), the current Total Assets is $1.77 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OWC Pharmaceutical Research Business Description

Address 2 Ben Gurion Street, Ramat Gan, ISR, 4514760
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.